The death of an Australian woman is believed to be connected to her getting AstraZeneca’s COVID-19 vaccine, authorities said Friday. The 48-year-old woman was admitted to a hospital with an extensive thromboembolic event, or blood clotting, and thrombocytopenia, or low blood platelet levels, four days after receiving the shot on April 8, according to Australia’s Vaccine Safety Investigation Group (VSIG). The woman died in the hospital. The group of investigators has concluded that the case “is likely linked to the vaccination.” The group is a panel of independent experts who advise the Therapeutic Goods Administration. It includes experts in vaccine safety, infectious disease immunology, and other fields. Panel members found the review of the case complicated by the woman’s underlying medical conditions, such as diabetes, but ultimately agreed that the case was consistent with causal association to immunization. An atypical characteristic when compared to other similar events in patients who got AstraZeneca’s jab …